Birdwatch Archive

Birdwatch Note Rating

2024-12-30 19:58:29 UTC - HELPFUL

Rated by Participant: EC1071DE271642F9BACDCDAD611F59FC37DE4B29FB2F3482E36F0592200A2C75
Participant Details

Original Note:

Vivek developed a drug for Alzheimer’s through a subsidiary of Roivant, Axovant. This drug failed, like most Alzheimer’s drugs. Vivek did not profit from it, choosing not to sell shares in Axovant before its collapse. Roivant also avoided such sales. Blatant lies in post. https://x.com/implisci/status/1697335207462883518

All Note Details

Original Tweet

All Information

  • noteId - 1873548470784610305
  • participantId -
  • raterParticipantId - EC1071DE271642F9BACDCDAD611F59FC37DE4B29FB2F3482E36F0592200A2C75
  • createdAtMillis - 1735588709427
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1873548470784610305EC1071DE271642F9BACDCDAD611F59FC37DE4B29FB2F3482E36F0592200A2C75